George Gauthier - May 13, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Commercial Officer
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
May 13, 2022
Transactions value $
$5,113
Form type
4
Date filed
5/17/2022, 06:57 PM
Previous filing
Mar 17, 2022
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $5.11K +413 +1.58% $12.38 26.6K May 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).